OR WAIT null SECS
Icahn School of Medicine at Mount Sinai
October 02, 2026
Video
Leon Kircik, MD, discusses unmet needs in atopic dermatitis, the rapid pace of new therapies, and emerging agents he is watching at EADV 2026.
Leon Kircik, MD, discusses phase 1b data for ENV-294, a first-in-class oral Rac2 modulator showing EASI reductions in atopic dermatitis.
September 16, 2026
Article
In this Q&A, Leon Kircik, MD, discusses challenging watch-and-wait for molluscum contagiosum with berdazimer gel, 10.3%, at LEADderm 2026.
September 08, 2026
Leon Kircik, MD, on why an FDA-approved, at-home molluscum option changes practice, and what is exciting for him in dermatology.